BrainTrip provides a fast, accurate, non-invasive, affordable and scalable neurological tool for early detection of dementia, answering the challenges of current screening methods. BrainTrip’s EEG-based measurement method takes just 15 minutes and results calculated in the cloud are instantly available to doctors and their patients via an app.

The Class I Medical Device certified BrainTrip Cognitive Index (BCI) is designed to detect the increasing prevalence of dementia in our ageing society with high accuracy at an early stage to help preserve and improve the quality of life of those affected and their families, and to reduce the burden on diagnostic specialists.